Magnesium supplementation is associated with high participant satisfaction and perceived improvements in sleep quality in adults with type 2 diabetes
In a cross-sectional survey of 132 participants from a randomized, double-blind clinical trial on magnesium supplementation in type 2 diabetes, 87.88% would recommend participation and over half reported symptom improvements, including in sleep quality. Satisfaction scores were consistently positive, with high internal consistency (Cronbach's alpha=0.93) and strong construct validity.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Magnesium supplementation is associated with high participant satisfaction and perceived improvements in sleep quality in adults with type 2 diabetes The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 32/100 (low).
The Claim
Magnesium supplementation is associated with high participant satisfaction and perceived improvements in sleep quality in adults with type 2 diabetes
This conclusion is most relevant to: Adults with type 2 diabetes participating in a clinical trial on magnesium supplementation.
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Assessment of Participant Satisfaction and Overall Experience: A Cross-Sectional Survey to Inform Trial Conduct. (Patient preference and adherence, 2026) —
How It Works
The proposed biological pathway:
- ▸Participants received magnesium supplementation
- ▸Survey assessed satisfaction and perceived health changes
- ▸Over half reported symptom improvements
- ▸High satisfaction and willingness to participate in future trials reported
Who Might Benefit
Evidence fit by population:
- ▸Adults with type 2 diabetes participating in a clinical trial on magnesium supplementation
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Cross-sectional survey design limits causal inference
- ▸Response rate of 58.15% may introduce non-response bias
- ▸Perceived symptom improvements are self-reported and not objectively measured
Frequently Asked Questions
What was the main finding regarding sleep quality?▼
Over half of participants reported symptom improvements, including in sleep quality, though no specific effect size was provided.
How many participants completed the survey?▼
132 out of 227 contacted participants completed the survey, yielding a response rate of 58.15%.
Was there a link between satisfaction and symptom improvement?▼
No significant association was found between satisfaction and symptom improvement.
What were the key factors for high satisfaction?▼
Staff professionalism, clear communication, and perceived health benefits were emphasized as key factors.
References
- 1.Al-Maqbali JS, Al Alawi AM, Al-Zakwani I, Al Za'abi M. “Assessment of Participant Satisfaction and Overall Experience: A Cross-Sectional Survey to Inform Trial Conduct..” Patient preference and adherence, 2026. PMID: 41847243 DOI: 10.2147/PPA.S589554